Annexon, Inc. (ANNX) Presents at Cantor Global Healthcare Conference 2025 Transcript
Question-and-Answer SessionDouglas LoveCEO, President & Director Yes. Hi, Pete, and thanks, Cantor, for welcoming Annexon to this year's conference. Happy to be here. I think this is our fifth or sixth in a row. So we're excited by that. So I'm Doug Love, as Pete said President and CEO of Annexon, Founding CEO of the company. We started the company roughly 10 years ago, focused on the classical complement pathway. And importantly, what's unique about our approach is we're targeting the most upstream aspect ...